PATENT CLAIM ANALYSIS

Application Number: 15971222
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "254110"]

Abstract:
This invention provides methods of treating motor disorder side effects associated with the administration of levodopa to a subject having Parkinson's disease, by administering a dose of eltoprazine or a pharmaceutically acceptable acid addition salt thereof. In particular, the invention provides methods for reducing dyskinesia associated with Parkinson's disease treatments, and effective doses of eltoprazine or a pharmaceutically acceptable acid addition salt thereof.

Claim (Index 7):
The method according to claim  4 , wherein said eltoprazine is administered at a dose of about 7.5 mg/day.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 93.0
- Lexical Diversity: 1.59091
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14937286', '13879128', '14395134', '14113340', '12994560']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7634049443600326
- 35 USC 102 Novelty (BERT): 0.533927270706347
- Combined Prediction Score: 0.7404571769946641
- Mean Citation Score: 304.350818
- Max Citation Score: 320.38098
- Similarity Product: 188.8351636824274

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test